packageEnfortumabVedotin

enfortumab vedotin

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Enfortumab vedotin, an antibody-drug conjugate, is used to treat urothelial (transitional cell) carcinoma. It is authorised in the European Union and is an approved cancer medicine, though it carries a boxed warning.

Summary written by glm-5.3-flash from Wikidata Q19904068 and the WHO ATC classification and the EMA medicines list; not checked by a person.

name:enfortumab vedotin
ATC codes:L01FX13
DrugBank:DB13007
Wikidata:Q19904068
molar mass:152000 g/mol (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown